Lonza collaborates with Oxford Nanopore to accelerate mRNA technology
Swiss contract drug manufacturer Lonza has partnered with Oxford Nanopore to enhance the analysis of mRNA products.
Source: biopharma-reporter.com
Page 20 - Rna News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rna Today - Breaking & Trending Today
Moderna leads development of mRNA vaccines in infectious diseases
The global messenger ribonucleic acid (mRNA) vaccine market currently consists entirely of vaccines for COVID-19.
Source: biopharma-reporter.com
Study: COVID-19 vaccination is 'strongly associated with a serious adverse safety signal of myocarditis'
The U.S. government, the mainstream media, and so-called experts long downplayed the possibility of a link between heart inflammation and COVID-19 vaccines. Elements of the medical establishment and social media companies worked to shut up those who dared to press the issue. Health officials a...
Source: theblaze.com
Sarah Boyce Sells 5,092 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CEO Sarah Boyce sold 5,092 shares of the company’s stock in a transaction on Monday, January 22nd. The shares were sold at an average price of $10.13, for a total value of $51,581.96. Following the completion of the transaction, the chief executive officer now owns 44,008 shares […]
Source: dailypolitical.com
Avidity Biosciences, Inc. (NASDAQ:RNA) CEO Sells $51,581.96 in Stock
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CEO Sarah Boyce sold 5,092 shares of the business’s stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $10.13, for a total value of $51,581.96. Following the sale, the chief executive officer now owns 44,008 shares of the company’s […]
Source: tickerreport.com